Detalles de la búsqueda
1.
Antibody-dependent cell-mediated cytotoxicity induced by active immunotherapy based on racotumomab in non-small cell lung cancer patients.
Cancer Immunol Immunother
; 67(8): 1285-1296, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29936534
2.
A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies.
Pediatr Blood Cancer
; 62(12): 2120-4, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26154941
3.
NGcGM3 ganglioside: a privileged target for cancer vaccines.
Clin Dev Immunol
; 2010: 814397, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21048926
4.
A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients.
Springerplus
; 4: 428, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26306290
5.
Anti-ganglioside antibodies induced in chickens by an alum-adsorbed anti-idiotype antibody targeting NeuGcGM3.
Front Immunol
; 3: 422, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-23335925
6.
Cellular and humoral immune response to N-Glycolyl-GM3 elicited by prolonged immunotherapy with an anti-idiotypic vaccine in high-risk and metastatic breast cancer patients.
J Immunother
; 29(2): 215-23, 2006.
Artículo
en Inglés
| MEDLINE | ID: mdl-16531822
7.
Active specific immunotherapy of melanoma with a GM3 ganglioside-based vaccine: a report on safety and immunogenicity.
J Immunother
; 27(6): 442-51, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15534488
Resultados
1 -
7
de 7
1
Próxima >
>>